Results 61 to 70 of about 107,331 (315)

Spatial and Temporal Clustering of Anti-Glomerular Basement Membrane Disease.

American Society of Nephrology. Clinical Journal, 2016
BACKGROUND AND OBJECTIVES An environmental trigger has been proposed as an inciting factor in the development of anti-GBM disease. This multicenter, observational study sought to define the national incidence of anti-GBM disease during an 11-year period (
M. Canney, P. O'Hara, Caitriona Mcevoy, S. Medani, Dervla M. Connaughton, A. Abdalla, Ross Doyle, A. Stack, C. O’Seaghdha, M. Clarkson, M. Griffin, J. Holian, A. Dorman, Aileen Niland, M. Keogan, E. Wallace, N. Conlon, C. Walsh, A. Kelly, M. Little   +19 more
semanticscholar   +1 more source

Concurrent Anti-glomerular Basement Membrane Nephritis and IgA Nephropathy [PDF]

Journal of Pathology and Translational Medicine, 2019
Anti–glomerular basement membrane (GBM) nephritis is characterized by circulating anti-GBM antibodies and crescentic glomerulonephritis (GN) with deposition of IgG along the GBM.
Kwang-Sun Suh, Song-Yi Choi, Go Eun Bae, Dae Eun Choi, Min-kyung Yeo   +4 more
doaj   +1 more source

Murine models of renal disease: Possibilities and problems in studies using mutant mice [PDF]

, 2000
The elucidation of the pathogenesis of human renal disease at the molecular level has been facilitated by the growing field of gene targeting and the development of mouse strains with single-gene deletions - the `knock-out' mice. Experimental nephrology,
Anders, Hans-Joachim, Schlöndorff, Detlef   +1 more
core   +1 more source

Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.

American Society of Nephrology. Clinical Journal, 2016
BACKGROUND AND OBJECTIVES Approximately 20%-30% of patients with anti-glomerular basement membrane disease present coexisting anti-myeloperoxidase (MPO) autoantibodies.
Jian-nan Li, Z. Cui, Jia Wang, Shui-Yi Hu, Xiao‐yu Jia, Zhe Guan, Min Chen, Can Xie, Ming-hui Zhao   +8 more
semanticscholar   +1 more source

Thin basement membrane disease – literature review

Journal of Medical Science, 2015
Initially, the thin glomerular basement membrane disease was called “a gentle and curable hemorrhagic nephritis”. The thin basement membrane disease has been finally characterized at the beginning of 1970s.
Jakub Żurawski
doaj   +1 more source

Idiopathic nodular glomerulosclerosis in a chronic marijuana user; a case report and review of the literature [PDF]

, 2017
Background: Nodular glomerulosclerosis is a characteristic histological finding of diabetic nephropathy (DN) with thickened glomerular basement membrane (GBM) and hyalinized arterioles.
Abdul Salim, Sohil, Fülöp, Tibor, Hamrahian, Seyed Mehrdad, Mollaee, Mehri   +3 more
core   +2 more sources

Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects [PDF]

, 2007
Cryoglobulinaemia may cause cutaneous vasculitis and glomerulonephritis, potentially leading to end stage renal failure. An important proportion of cryoglobulinaemias are secondary to hepatitis C virus infection.
Braun, Gerald S., Horster, Sophia, Ihrler, Stephan, Schmid, Holger, Wagner, Katrin S.   +4 more
core   +2 more sources

Anti-Glomerular Basement Membrane Disease [PDF]

Journal of the American Society of Nephrology, 1999
Anti-glomerular basement membrane disease (anti-GBM) is a rare but well-characterized cause of glomerulonephritis. It is defined by the presence of autoantibodies directed at specific antigenic targets within the glomerular and/or pulmonary basement membrane.
Andrew J. Rees, David C. Kluth
openaire   +3 more sources

Atypical anti-glomerular basement membrane disease

Clinical Kidney Journal, 2015
Background Anti-glomerular basement membrane (anti-GBM) disease classically presents with aggressive necrotizing and crescentic glomerulonephritis, often with pulmonary hemorrhage.
M. Troxell, D. Houghton
semanticscholar   +1 more source

Engineered 3D Kidney Glomerular Microtissues to Model Podocyte‐Centric Diseases for the Validation of New Drug Targets

Advanced Healthcare Materials, EarlyView.
The study introduces innovative 3D microtissues that replicate the glomerular filtration barrier of the kidney, offering a novel platform for understanding podocytopathies. These microtissues simulate the glomerulus's structure and dynamics, allowing for the modeling of podocyte injuries and drug testing.
Sara Buttό, Solange Vidal, Xi Rui Zeng, Martin Rausch, Immihan Ceren Yasa, Magali P. Ferro   +5 more
wiley   +1 more source